现代医学研究发现,传统中药在促进造血方面取得了令人瞩目的进展,多种中药可通过多种复杂的机制发挥其促造血作用。在传统医学中,造血过程被认为与气血的生成相关。研究表明许多中药及其活性成分可通过保护及促进造血干细胞增殖及分化...现代医学研究发现,传统中药在促进造血方面取得了令人瞩目的进展,多种中药可通过多种复杂的机制发挥其促造血作用。在传统医学中,造血过程被认为与气血的生成相关。研究表明许多中药及其活性成分可通过保护及促进造血干细胞增殖及分化、调节造血微环境、调控造血生长因子、激活造血相关信号通路等方式发挥促造血作用,许多中药有望成为血液系统疾病治疗的良好制剂。文章综述了中药促造血机制,以及近年来研究发现具有促造血作用的补气药及补血药。中药活性成分的复杂性和多样性使得其机制的研究变得困难,中药的标准化和质量控制问题亟需解决。随着对中药活性成分的深入研究,越来越多的中药制剂被应用于临床造血功能障碍的治疗。总的来说,传统中药及其活性成分在造血过程中的研究正在不断深入,未来将展现出广阔的发展前景。Modern medical research has found that traditional Chinese medicine has made remarkable progress in promoting hematopoiesis, and a variety of traditional Chinese medicines can exert their hematopoietic effects through a variety of complex mechanisms. In traditional medicine, the hematopoietic process is thought to be associated with the production of Qi and blood. Studies have shown that many traditional Chinese medicines and their active ingredients can play a role in promoting hematopoiesis by protecting and promoting the proliferation and differentiation of hematopoietic stem cells, regulating the hematopoietic microenvironment, regulating hematopoietic growth factors, and activating hematopoietic-related signaling pathways, and many TCMs are expected to become good preparations for the treatment of hematopoietic diseases. This article reviews the hematopoietic mechanism of traditional Chinese medicine, as well as the Qi tonic drugs and blood tonic drugs that have been found to promote hematopoiesis in recent years. The complexity and diversity of active ingredients in traditional Chinese medicine make it difficult to study their mechanisms, and the standardization and quality control of traditional Chinese medicine needs to be solved urgently. With in-depth research on the active ingredients of traditional Chinese medicine, more and more traditional Chinese medicine preparations are used in the treatment of clinical hematopoietic dysfunction. In general, the research on traditional Chinese medicine and its active ingredients in the hematopoietic process is deepening, and it will show broad development prospects in the future.展开更多
目的:通过1例以皮肤损害为首发症状的结外NK/T细胞淋巴瘤的病例,探讨该病例诊治线索及治疗时机。方法:回顾性分析我院1例皮肤损害为首发症状的结外NK/T细胞淋巴瘤临床表现、诊治思路、治疗结局,并进行相关文献复习。结果:该例患者因肿...目的:通过1例以皮肤损害为首发症状的结外NK/T细胞淋巴瘤的病例,探讨该病例诊治线索及治疗时机。方法:回顾性分析我院1例皮肤损害为首发症状的结外NK/T细胞淋巴瘤临床表现、诊治思路、治疗结局,并进行相关文献复习。结果:该例患者因肿瘤转移合并感染,最终自动出院。结论:以皮肤损害为首发症状的结外NK/T细胞淋巴瘤患者的早期诊断及治疗十分重要。Objective: A case of extranodal NK/T cell lymphoma with skin lesion as the first symptom was studied to explore the clues of diagnosis and treatment and the opportunity of treatment. Methods: The clinical manifestations, diagnosis and treatment ideas, and treatment outcome of 1 case of extranodal NK/T cell lymphoma with skin lesion as the first symptom in our hospital were retrospectively analyzed, and the relevant literature was reviewed. Results: The patient was discharged automatically due to tumor metastasis and infection. Conclusions: Early diagnosis and treatment of extranodal NK/T cell lymphoma with skin lesion as the first symptom are very important.展开更多
文摘现代医学研究发现,传统中药在促进造血方面取得了令人瞩目的进展,多种中药可通过多种复杂的机制发挥其促造血作用。在传统医学中,造血过程被认为与气血的生成相关。研究表明许多中药及其活性成分可通过保护及促进造血干细胞增殖及分化、调节造血微环境、调控造血生长因子、激活造血相关信号通路等方式发挥促造血作用,许多中药有望成为血液系统疾病治疗的良好制剂。文章综述了中药促造血机制,以及近年来研究发现具有促造血作用的补气药及补血药。中药活性成分的复杂性和多样性使得其机制的研究变得困难,中药的标准化和质量控制问题亟需解决。随着对中药活性成分的深入研究,越来越多的中药制剂被应用于临床造血功能障碍的治疗。总的来说,传统中药及其活性成分在造血过程中的研究正在不断深入,未来将展现出广阔的发展前景。Modern medical research has found that traditional Chinese medicine has made remarkable progress in promoting hematopoiesis, and a variety of traditional Chinese medicines can exert their hematopoietic effects through a variety of complex mechanisms. In traditional medicine, the hematopoietic process is thought to be associated with the production of Qi and blood. Studies have shown that many traditional Chinese medicines and their active ingredients can play a role in promoting hematopoiesis by protecting and promoting the proliferation and differentiation of hematopoietic stem cells, regulating the hematopoietic microenvironment, regulating hematopoietic growth factors, and activating hematopoietic-related signaling pathways, and many TCMs are expected to become good preparations for the treatment of hematopoietic diseases. This article reviews the hematopoietic mechanism of traditional Chinese medicine, as well as the Qi tonic drugs and blood tonic drugs that have been found to promote hematopoiesis in recent years. The complexity and diversity of active ingredients in traditional Chinese medicine make it difficult to study their mechanisms, and the standardization and quality control of traditional Chinese medicine needs to be solved urgently. With in-depth research on the active ingredients of traditional Chinese medicine, more and more traditional Chinese medicine preparations are used in the treatment of clinical hematopoietic dysfunction. In general, the research on traditional Chinese medicine and its active ingredients in the hematopoietic process is deepening, and it will show broad development prospects in the future.
文摘目的:通过1例以皮肤损害为首发症状的结外NK/T细胞淋巴瘤的病例,探讨该病例诊治线索及治疗时机。方法:回顾性分析我院1例皮肤损害为首发症状的结外NK/T细胞淋巴瘤临床表现、诊治思路、治疗结局,并进行相关文献复习。结果:该例患者因肿瘤转移合并感染,最终自动出院。结论:以皮肤损害为首发症状的结外NK/T细胞淋巴瘤患者的早期诊断及治疗十分重要。Objective: A case of extranodal NK/T cell lymphoma with skin lesion as the first symptom was studied to explore the clues of diagnosis and treatment and the opportunity of treatment. Methods: The clinical manifestations, diagnosis and treatment ideas, and treatment outcome of 1 case of extranodal NK/T cell lymphoma with skin lesion as the first symptom in our hospital were retrospectively analyzed, and the relevant literature was reviewed. Results: The patient was discharged automatically due to tumor metastasis and infection. Conclusions: Early diagnosis and treatment of extranodal NK/T cell lymphoma with skin lesion as the first symptom are very important.
